NLIGHT, INC. (LASR): what the price assumes

In the published model solve dated 2026-Q2, anchored at $58.83, NLIGHT, INC. (LASR) is priced for today's economics sustained for ~25.7 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/LASR

Headline

FieldValue
TickerLASR
CompanyNLIGHT, INC.
Current price$58.83/sh
CompositionAerospace and Defense 67% / Microfabrication 18% / Industrial 15%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid10.5x
Steady-state operating margin assumed11.9%
Must persist for25.7y

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 13.5% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~3.4 years.

Reconcile: at the x-ray's 9.3% required return this reads ~14 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history+0.81σ
sustained it ~10 years at this level15%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset8.16x2expensive
Earnings6.65x1expensive
Relative2.29x2expensive
Growth1.13x3expensive

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=8)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$25.482.31xyesFCF base $0.0B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.2%, 7yr projection
DCF Exit MultipleGrowth$0.00—noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$25.692.29xyesP/S fallback (negative EPS): Sector P/S 5.0x × TTM revenue — excluded from consensus
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$7.617.73xyesBook value floor: BV/sh $7.61, ROE negative
Two-Stage Excess ReturnAsset$6.858.59xyesBook value with convergence: BV/sh $7.61, ROE converges to ke
Discounted Future Market CapGrowth$85.360.69xyesRev $0.3B, growth 30% (input: historical growth; tapered), Terminal P/S: 9.2x / 11.4x / 13.7x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00—noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth$52.231.13xyesMargin ramp: -5% → 25% over 7yr, rev growth 30% (input: historical growth; tapered)
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset——no—
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings$8.846.65xyesFCF $22.2M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings——no—
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$25.692.29xyesRevenue $0.29B × sector P/S 5.0x
PEG Fair ValueRelative——no—
Earnings YieldEarnings——no—
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net cash$332.6m
Interest coverage-13.2x
Share count CAGR (dilution)8.3%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Bullet Takeaways

Bull Case

Defense lasers are an unusually hard thing to price, and that is the whole bull case. A directed-energy weapons supplier has almost no trailing earnings to anchor on, a customer base of one government with multi-year procurement cycles, and a market that barely existed at scale a few years ago. The standard machinery, earnings multiples and book value, reads a company like this as expensive by construction, because the profit it is being bought for has not arrived yet. nLIGHT sits squarely in that gap. Its 10-K is explicit that lasers are "used today in a variety of aerospace and" defense applications, and the segment behind that sentence has become the company.

The shape of the business has genuinely inverted. The filing describes recent growth as the result "of increased revenue from the Aerospace and Defense market, partially offset by decreased revenue from the Microfabrication and Industrial markets", which is the company telling you in its own words that the legacy industrial lines are shrinking while the defense franchise carries the load. That is the right direction for a supplier trying to escape commodity laser pricing. Aerospace and defense is now the weighted heart of the business, with microfabrication and industrial reduced to roughly a third between them. The customer is the U.S. government, and the demand signal is high-energy laser weapon programs that move on budget cycles rather than the consumer-electronics whipsaw that punished the old nLIGHT.

The balance sheet lets the company wait for that demand to mature. nLIGHT carries about $333 million in cash against no funded debt, a net-cash position that is large relative to its trailing revenue. A directed-energy program can slip a quarter or a year without putting the company at risk, because there is no leverage to service and the cash covers the gap. The bull does not need the trailing numbers to look good. It needs the defense backlog to convert, the cash to fund the wait, and the laser-weapon budget line to keep growing. Those are the variables, and the company has positioned itself directly in their path.

Bear Case

The advantage nLIGHT is supposed to defend is thinner than the share price assumes, and the place to see it is the legacy business. The same disclosure that celebrates defense growth also records it as "partially offset by decreased revenue from the Microfabrication and Industrial markets". Those industrial and microfabrication lines are where nLIGHT once competed on engineering, and they are eroding. The fiber-laser market is crowded with established power-electronics and photonics suppliers, and the company concedes that "any newly developed or enhanced products may not achieve market acceptance or may be rendered obsolete or less competitive by the introduction of new products by other companies". A moat that needs constant re-proving against larger competitors is not a moat; it is a treadmill.

The customer concentration makes the erosion dangerous rather than merely slow. nLIGHT warns that if "any of our principal customers discontinues its relationship with us for any reason, then our business, financial condition, results of operations and growth prospects could be materially adversely affected", and the defense pivot has only deepened that dependence on a single government buyer with its own budget politics. The company also "generally do not enter into long-term purchase commitments with our customers", so the backlog that excites the bull is less locked in than it sounds. Revenue that is hard to predict and concentrated in one customer is exactly the profile that turns a soft program year into a sharp downgrade.

Then there is what the price requires. At about 12.8 times revenue, today's quote assumes the business eventually reaches roughly a 12% operating margin and grows at its self-funding ceiling for the better part of three decades. It earns a negative operating margin today. None of the standard valuation families, asset value, earnings power, peer multiples, or even forward growth, reaches the current price; every one of them sits well below it. That is the definition of a bet beyond what any conventional frame supports. If the directed-energy ramp stalls or the margin tops out short of what is assumed, the multiple has nothing underneath it, and the share count is still climbing about 8% a year, diluting whatever value does eventually arrive.

Valuation

Start with what the price is betting, because none of the usual anchors apply. nLIGHT does not earn an operating profit on a trailing basis, so the market cannot be pricing earnings; it is pricing sales, at about 12.8 times revenue. Inverted, that price assumes the company eventually runs at roughly an 11.9% operating margin and grows revenue at close to its self-funding ceiling for nearly three decades. The 10-K reports the defense franchise as the driver, with growth coming "of increased revenue from the Aerospace and Defense market", but the duration the price demands is the demanding part. The recent growth rate is within reach of what the company has shown; sustaining it for that long is what history rarely delivers, and only about 15% of comparable fast-growers held a pace like this even a decade.

The methods agree on one thing, which is that none of them reaches the price. The asset-value lens lands near book value, far below the quote. The earnings-power methods, working off free cash flow, sit a fraction of the price. Peer multiples on a sales basis reach roughly a third of it. Even the forward-growth methods, which credit aggressive revenue compounding, come up short. When every family is below the price and the most generous one still cannot close the gap, the price is not an overvaluation argument against one method; it is a bet beyond what any standard frame supports. The spread is the information, and here the spread is wide in every direction.

Solvency is the one place the picture is genuinely strong, and it bounds the downside. nLIGHT holds about $333 million in cash with no funded debt, which is substantial against its revenue base and means the company is not burning toward a financing event. That cushion is what makes the long-duration bet survivable, because it can fund years of program development without dilution-by-necessity. The offset is that the share count is already rising around 8% a year, so even a successful ramp arrives spread across more shares. The net-cash floor is real; the equity above it is paying entirely for a defense margin the company has not yet demonstrated.

Catalysts

The most recent print reframed the story. In the first quarter of 2026 nLIGHT reported record revenue of $80.2 million, up 55% year over year, and swung to a small net profit of about $0.6 million, with aerospace and defense revenue of $55.1 million growing 69%. Record A&D product revenue rose 98% year over year, and management pointed to a defense backlog around $110 million tied to high-energy laser weapon programs with U.S. Army and Navy customers. That is the conversion the bull case needs, showing up where it cannot be faked, in the revenue line.

The near-term driver is the formal launch of the company's scalable high-energy laser platform with integrated atmospheric correction, which positions nLIGHT for the prototype-and-procurement phase of directed-energy spending. Management has framed the addressable opportunity around the U.S. government fiscal 2027 and 2028 budgets, which it cites as carrying close to $400 million for directed-energy prototypes and procurement within an annual laser-weapons budget approaching $1 billion. Management also said it sees no current capacity constraints on fulfilling new awards.

What to watch is the cadence of those awards converting into shipped product. The company has told investors the demand signal is strengthening; the test over the next several quarters is whether defense product revenue keeps compounding at the recent pace or whether program timing introduces the lumpiness the company warns about. Each quarterly defense revenue figure is the cleanest read on whether the long-duration bet embedded in the price is being earned.

Peer Cohorts (Per Segment, With Filing Citations)

Laser Products (reported)

Advanced Development (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

nLIGHT Q1 2026 earnings release, May 2026 · nLIGHT Q1 2026 earnings call, May 2026

View the full interactive LASR report on boothcheck